KaloBios Pharmaceuticals Inc. Hits New 52-Week Low at $4.61 (KBIO)
KaloBios Pharmaceuticals (NASDAQ:KBIO) set a new 52-week low during trading on Wednesday, AnalystRatingsNetwork reports. The stock traded as low as $4.61 and last traded at $4.66, with a volume of 363,865 shares. The stock had previously closed at $5.46.
KaloBios Pharmaceuticals has a 1-year low of $4.81 and a 1-year high of $8.25. The stock has a 50-day moving average of $5.74 and a 200-day moving average of $5.77. The company’s market cap is $112.1 million.
KaloBios Pharmaceuticals, Inc, is a United States-based company, which develops protein therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.